CME Group Inc (NASDAQ:CME) insider Jack J. Tobin sold 2,325 shares of CME Group stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $152.28, for a total transaction of $354,051.00. Following the sale, the insider now owns 17,574 shares in the company, valued at $2,676,168.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of CME Group Inc (NASDAQ:CME) traded up $0.21 during trading on Tuesday, reaching $151.28. 1,400,300 shares of the company’s stock traded hands, compared to its average volume of 1,378,638. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group Inc has a 12-month low of $113.27 and a 12-month high of $155.29. The company has a market capitalization of $51,230.11, a PE ratio of 31.60, a PEG ratio of 3.10 and a beta of 0.73.
CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. During the same period in the previous year, the business earned $1.05 earnings per share. CME Group’s revenue for the quarter was up 5.8% compared to the same quarter last year. equities research analysts anticipate that CME Group Inc will post 4.78 EPS for the current fiscal year.
CME has been the topic of a number of recent analyst reports. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 6th. Citigroup lifted their price objective on shares of CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. UBS restated a “buy” rating and set a $135.00 price objective (up from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Keefe, Bruyette & Woods restated a “hold” rating and set a $133.00 price objective on shares of CME Group in a research note on Thursday, September 21st. Finally, Wells Fargo & Company boosted their price target on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, October 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the stock. CME Group has an average rating of “Buy” and an average target price of $141.75.
A number of institutional investors have recently modified their holdings of CME. Fiduciary Trust Co. purchased a new position in CME Group in the 2nd quarter worth about $105,000. Quadrant Capital Group LLC increased its stake in CME Group by 13.6% in the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after purchasing an additional 113 shares in the last quarter. Valeo Financial Advisors LLC purchased a new position in CME Group in the 3rd quarter worth about $124,000. San Francisco Sentry Investment Group CA purchased a new position in CME Group in the 2nd quarter worth about $129,000. Finally, People s United Financial Inc. increased its stake in CME Group by 11.5% in the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after purchasing an additional 110 shares in the last quarter. Hedge funds and other institutional investors own 82.70% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://sportsperspectives.com/2017/12/19/jack-j-tobin-sells-2325-shares-of-cme-group-inc-cme-stock.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.